Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Provectus Biopharmaceuticals Inc (NYSE MKT LLC:PVCT)

0.0971
Delayed Data
As of 4:01pm ET
 -0.0067 / -6.45%
Today’s Change
0.09
Today|||52-Week Range
0.60
-75.10%
Year-to-Date
No recent news for Provectus Biopharmaceuticals Inc.

Today’s Trading

Previous close0.10
Today’s open0.11
Day’s range0.10 - 0.11
Volume2,469,097
Average volume (3 months)1,684,879
Market cap$22.1M
Dividend yield--
Data as of 4:01pm ET, 09/29/2016

Growth & Valuation

Earnings growth (last year)-116.67%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.30

Competitors

 Today’s
change
Today’s
% change
WINTWindtree Therapeutic...-0.02-0.75%
MSTXMast Therapeutics In...-0.01-4.99%
OPXAOpexa Therapeutics I...+0.06+1.89%
MBVXMabVax Therapeutics ...+0.08+1.96%
Data as of 4:02pm ET, 09/29/2016

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$0.00
Annual profit (last year)-$24.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
CEO, Chief Operating &
Accounting Officer
Peter R. Culpepper
President &
Director
Timothy C. Scott
Corporate headquarters
Knoxville, Tennessee

Forecasts

Search for Jobs